Historical record - last NADAC effective date: 2/21/2024
Product Information
CLOBETASOL 0.05% SOLUTION is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3618 per ML under NDC 68462053228. Its NADAC has been published 297 times since Jun 20, 2018.
FDA first approved this application on Apr 18, 2018.
Strength
.5 mg/mL
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462053228
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
2/21/2024
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA210190FDA Approved
4/18/2018
On Market Since
4/18/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% SOLUTION has been published 297 times since Jun 20, 2018, and over the history we have for it it has declined 58.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3618 per ML |
|---|---|
| All-time high | $0.9331 (Nov 14, 2018) |
| All-time low | $0.3618 (Feb 21, 2024) |
| Median price | $0.6422 |
| Average price | $0.6354 |
| Largest weekly change | -32.3% (Dec 22, 2021) |
| Weeks tracked | 297 |
| Tracking since | Jun 20, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.3%
5Y
-42.8%
All
-58.5%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOBETASOL PROPIONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% SOLUTION, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3618 per ML (NDC 68462053228), effective Feb 21, 2024.
How has the price of CLOBETASOL 0.05% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% SOLUTION has declined 58.5%. It has been tracked across 297 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% SOLUTION?
Since Jun 20, 2018, the NADAC for CLOBETASOL 0.05% SOLUTION has ranged from a low of $0.3618 (Feb 21, 2024) to a high of $0.9331 (Nov 14, 2018), with a median of $0.6422 per ML.
Are there cheaper alternatives to CLOBETASOL 0.05% SOLUTION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% SOLUTION, is $0.1359 per ML — about 62% below CLOBETASOL 0.05% SOLUTION.
Who manufactures CLOBETASOL 0.05% SOLUTION?
CLOBETASOL 0.05% SOLUTION (NDC 68462053228) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.